2.5
그레이브스병은 갑상선기능항진증, 즉 갑상선의 과활동을 유발하는 자가면역 질환입니다. 이 질환은 갑상선자극면역글로불린, 또는 TSI라고 하는 자가항체가 갑상선자극호르몬, 또는 TSH 수용체에 결합하여 발생하며, 그 결과 호르몬 생성이 과도하게 자극되고 과대사 상태가 초래…
그레이브스병은 자가면역 질환이며 갑상선 기능 항진증의 주요 원인입니다. 면역 체계가 갑상선을 비정상적으로 활성화시키는 자가항체인 갑상선 자극 면역글로불린을 생성할 때 발생합니다.
이 항체들은 갑상선의 TSH 수용체에 결합하여 갑상선 호르몬의 과도한 생성을 초래합니다.
이로 인해 신체의 신진대사율이 증가하고 심박수와 체온 조절과 같은 기능에 영향을 미칩니다.
그레이브스병은 유전적 소인, 특히 HLA-DR3와 HLA-B8 변이와 흡연, 스트레스 같은 환경적 유발 요인과 연관되어 있습니다.
이러한 특정 HLA 유형은 갑상선 단백질을 변형하여 자가반응성 T 세포를 활성화할 가능성을 높이고, 결과적으로 그레이브스병 발병 위험을 높입니다.
임상적으로는 체중 감소, 열에 불내증, 심계항진, 생리 불규칙 등 갑상선기능항진증 증상을 보입니다.
갑상선종, 즉 갑상선이 커진 것이 보통 존재합니다. 안병증은 외안과 안와 부종이 특징이며, 이 특징이 특징입니다.
View the full transcript and gain access to JoVE Core videos
Q1: What causes Graves' disease to develop?
Graves' disease develops when the immune system produces thyroid-stimulating immunoglobulins, autoantibodies that abnormally activate the thyroid gland. These antibodies bind to TSH receptors on thyroid cells, triggering excessive hormone production. The condition combines genetic predisposition—particularly HLA-DR3 and HLA-B8 variants—with environmental triggers such as smoking, stress, and viral infections.
Q2: How do thyroid-stimulating immunoglobulins affect the body?
Thyroid-stimulating immunoglobulins bind to TSH receptors on the thyroid gland, leading to excessive production of thyroid hormones. This increases the body's metabolic rate and disrupts functions such as heart rate and temperature regulation, creating a hypermetabolic state characteristic of hyperthyroidism.
Q3: What are the main clinical symptoms of Graves' disease?
Graves' disease presents with weight loss, heat intolerance, palpitations, tachycardia, tremors, anxiety, and menstrual irregularities. A diffuse goiter typically causes visible neck swelling. Ophthalmopathy, a distinctive autoimmune feature, includes exophthalmos, eye dryness, redness, and in severe cases, visual disturbances or pain.
Q4: What role do genetic factors play in Graves' disease?
Graves' disease has a strong genetic component, with increased prevalence in individuals carrying HLA-DR3 and HLA-B8 alleles. These specific HLA types present thyroid proteins in an altered manner, increasing the likelihood of activating autoreactive T cells. Family clustering and higher concordance in monozygotic twins demonstrate the hereditary nature of susceptibility.
Q5: How is Graves' disease related to other autoimmune disorders?
Graves' disease is associated with other autoimmune disorders such as type 1 diabetes and pernicious anemia, indicating underlying immune dysfunction. This clustering suggests shared genetic predisposition and common mechanisms of immune dysregulation that increase risk for multiple autoimmune conditions simultaneously.
Q6: What is ophthalmopathy and how does it manifest in Graves' disease?
Ophthalmopathy is a distinctive autoimmune feature of Graves' disease characterized by exophthalmos, or forward bulging of the eyes, along with periorbital edema. Patients experience eye dryness, redness, tearing, and diplopia. In severe cases, visual disturbances or pain may occur, making ophthalmopathy a defining clinical marker.
Q7: What environmental factors can trigger or worsen Graves' disease?
Environmental triggers include smoking, which significantly aggravates ophthalmopathy, viral infections through molecular mimicry mechanisms, emotional stress, and excess iodine intake. These factors interact with genetic predisposition to disrupt immune regulation, leading to B-cell production of thyroid-stimulating immunoglobulins and disease initiation or progression.